149 related articles for article (PubMed ID: 34533252)
21. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
[TBL] [Abstract][Full Text] [Related]
22. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
[TBL] [Abstract][Full Text] [Related]
23. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
24. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
[TBL] [Abstract][Full Text] [Related]
25. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Wang J; Jiang W
Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
[TBL] [Abstract][Full Text] [Related]
26. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
28. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
29. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
30. Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes.
Sheu WH; Gantz I; Chen M; Suryawanshi S; Mirza A; Goldstein BJ; Kaufman KD; Engel SS
Diabetes Care; 2015 Nov; 38(11):2106-14. PubMed ID: 26310692
[TBL] [Abstract][Full Text] [Related]
31. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
32. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
Zhang W; Sun Y; Liu W; Dong J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
[TBL] [Abstract][Full Text] [Related]
35. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
36. Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease.
Yang L; Ma Q; Chen J; Kong X; Yu X; Wang W
PeerJ; 2023; 11():e16466. PubMed ID: 38084145
[TBL] [Abstract][Full Text] [Related]
37. Electroacupuncture Attenuates Liver Inflammation in Nonalcoholic Fatty Liver Disease Rats.
Ma B; Li P; An H; Song Z
Inflammation; 2020 Dec; 43(6):2372-2378. PubMed ID: 32737656
[TBL] [Abstract][Full Text] [Related]
38. Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease.
Ore A; Akinloye OA; Adeogun AI; Ugbaja RN; Morifi E; Makatini M; Moepya R; Mbhele T
J Food Biochem; 2022 Mar; 46(3):e13836. PubMed ID: 34184286
[TBL] [Abstract][Full Text] [Related]
39. JIP3 knockout protects mice against high fat diet-induced liver injury.
Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
[TBL] [Abstract][Full Text] [Related]
40. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
Li C; Liu Q; Xie L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]